July 2014

Making progress ()
Epidemiological approach may help to combat healthcare cybercrimes ()
Menopausal hormone therapy & cardiovascular disease: It’s a wash ()
MidMichigan Health appoints new service line directors ()
Dr. Robert Hendel named interim chief of cardiovascular division ()
European Commission approves Eliquis (apixaban) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE ()
Detroit Medical Center opens DMC Heart Hospital ()
Use of quality measures prevents kidney injuries in 1 in 5 PCI patients ()
Timely care for off-hours STEMI still lags in hospitals ()
Infections after cardiac surgery common, with many avoidable ()
Cardioxyl Pharmaceuticals successful first clinical trial for heart failure drug CXL-1427 ()
Arizona increases cardiac arrest survival through centralized out-of-hospital care ()
St. Jude Medical announces CE Mark approval and first use of the FlexAbility Ablation Catheter ()
Medtronic and Lifetech Scientific Corporation expand strategic alliance ()
Older patients with severe dementia 2.9 times more likely to receive pacemaker ()
Many patients unaware of options, risks with ICD replacement ()
Boston Scientific launches POLARIS Imaging System ()
Boston Scientific receives CE mark for agent drug-coated balloon ()
As is, readmissions penalty may push some hospitals over brink ()
Hybrid coronary revascularization fails to catch on in U.S. ()
No benefit in pregnancy TIPPS scales against heparin ()
Meta-analysis finds sex differences in acute MI hard to track ()
8 cardiologists choose private practice over new contract ()
57% say 'no' to starting statins despite patient's 10.9% risk score ()
FDA dilemma: When apps race ahead of regulatory prowess ()
LSE and ESC announce the launch of a new executive-style MSc to train the next generation of leaders in cardiovascular sciences ()
NewYork-Presbyterian Hospital names new senior vice president for quality and patient safety ()
Esperion Therapeutics announces initiation of a phase 2 clinical study of ETC-1002 in patients with hypercholesterolemia and hypertension ()
Perspective on Pradaxa ()
Shared decision-making: How to choose best approach ()
Spectranetics announces FDA clearance of peripheral laser atherectomy devices for in-stent restenosis ()
Journal takes deep dive into dabigatran’s safety data ()
FDA approves Rebel bare-metal stent ()
Cholesterol guidelines offer men benefits beyond heart disease ()
The heart of an astronaut, five years on ()
Atherectomy-filter combo safe, effective for PAD ()
Lackluster AMI rates in middle-age adults reveal gaps ()
BIOTRONIK announces completion of enrollment in SFA arm of the BIOFLEX-I study ()
Beware of racketeers making big money on patient records ()
Anticoagulants hold edge over catheter approach for DVT ()
CCTA: Shedding light on appropriateness of repeat scans ()
LGE helps ID at-risk aortic valve replacement patients ()
Score predicts patients at risk of ICD testing glitch ()
Can pregnancy loss predict cardiovascular disease in post-menopausal women? ()
How reducing physician pay ultimately bloats costs ()
Heart-breaking benders: Liquor, wine, binge drinking may raise risk of AF ()
NIH system to monitor emerging drug trends ()
Negative for niacin: HPS2-THRIVE shows spike in hazards ()
EHR, automated checks help diagnose hypertension ()
ACE broadens its accreditation and quality review services to include all invasive cardiovascular specialties ()
Bristol-Myers Squibb and Pfizer announce enrollment of first patient in Phase IV EMANATE trial to assess effectiveness and safety of Eliquis (apixaban) in patients with NVAF undergoing cardioversion ()
Stroke trends ()
Pigs and pacemakers ()
Boston Scientific receives CE Mark for the new 25 mm Lotus Valve System ()
Surgical patients at increased risk up to 9 months post-stroke ()
1 in 38 ICD patients experience major complications to lead revisions ()
Shifting cultures ()
AHA to insurers: Home BP monitoring saves you money ()
Stroke differences dissolve by race, sex but not age ()
The Need for Real-time Skin Dose Tracking ()
A plum for Cleveland: Clinic gets top cardiology ranking ()
Physicians implant world's first ProMRI Quadripolar CRT-D System to treat heart failure ()
CardioVascular Institute trial provides treatment for left-sided heart failure ()
Follow-up costs outweigh benefits for nodule findings on CCTA ()
Gap between imaging, therapy stymies swift stroke care ()
Boston Scientific receives CE Mark for Ranger Drug-Coated Balloon ()
480 Biomedical awarded $1 Million Phase II NHLBI contract to advance bioresorbable scaffold for pediatric pulmonary artery stenosis ()
CVIS market to top $211M by 2018 ()
Hospital saves $1.25M by nixing excess cardiac biomarker testing ()
Genetic study questions wine’s cardiovascular benefits ()
Senate panel puts CMS in hot seat over onerous audits ()
Meta-analysis finds 2.5-fold higher pacemaker risk with CoreValve ()
Most cardiac patients commit medication errors after discharge ()
Children’s Hospital Los Angeles taps interventional cardiologist Frank Ing, MD, to co-direct Heart Institute and head division of cardiology ()
Stroke rates decline in U.S. among elderly patients ()
Trickle-up economics ()
Patient safety indicators give endo edge over open AAA repair ()
Device size, failure mode affect outcomes after valve-in-valve procedure ()
Bristol-Meyers Squibb recalls injectable Coumadin ()
USPSTF: No screening for asymptomatic carotid artery stenosis ()
Most physicians see income drop or stagnate in past year ()
AstraZeneca and Max Planck Institute announce research agreement to create satellite chemistry unit for cardiovascular and metabolic diseases ()
Pacemaker coders: Mind you Ps, Qs and KXs ()
Women bore brunt of initial NCD for TAVR ()
Sitagliptin in diabetic HF patients: Less mortality, more HF hospitalizations ()
Low-dose heparin in radial PCI rivals bivalirudin at a fraction of its cost ()
Cardiac demo’s cost savings may support wider rollout ()
Dabigatran on par with warfarin for in-hospital mortality ()
At 2 years, zotarolimus-eluting stents safe, effective in patients with diabetes ()
Dr. Thomas Wakefield named a director of U-M Frankel Cardiovascular Center ()
Everolimus-eluting stents safe, effective in complex patients at 1 year ()
Thoratec buys maker of transapical systems for $35M ()
Improving habits has a positive impact on heart health ()
21% of newly diagnosed heart failure patients don’t undergo cardiovascular testing ()
AHA awards $15M to 4 centers targeting heart disease, stroke ()
Some prasugrel prescribing runs counter to labeling ()
Variable post-CABG infection rates may hinge on hospital, surgeon-level factors ()
Diet dynamics: More olive oil, less risk of AF ()
Texas Children's Heart Center welcomes two new physicians dedicated to providing care to pediatric and adult patients with congenital heart disease ()
Surgeons warn against use of Mitroflow valve in young patients ()
A little too personalized medicine? ()
PCI volume-outcome link holds but threshold is unclear ()
Device monitoring allows more defined AF classifications ()